Accurate and tailored low dependency solutions, designed for maximum efficiency.
However, the decade ahead is critical for securing a sustainable future for us all
Why the Competition and Markets Authority’s compulsory tendering requirements for Fiduciary Management may hinder smaller schemes?
Helping you reach your funding goals
A commitment shared
ESG solutions for charities
FIND OUT MORE
The value of investments and any income derived from them can go down as well as up as a result of market or currency movements and investors may not get back the original amount invested.
Innovative and award-winning tools for pension schemes and insurance companies.
Responsible solutions from a pioneer in ESG investing.
A delegated investment solution you can trust.
A range of solutions built from wide ranging capabilities in bond investing.
Systematically targeting the performance potential of style investing.
Real assets with real potential – investing directly and indirectly in property.
Actively targeting growth potential at its most potent.
Outcome orientated active investing across asset classes.
A wide range of news and views articles from our fund managers, economists and industry experts
Discover our views on the future of cities as life opens up after the pandemic.
Keep up to date with responsible investing through our monthly roundup of highlights – interesting events, articles we’re reading, podcasts we’re enjoying and more.
Macro Update 12 April 2021
This month we feature our quarterly repo update.
The prospect of a vaccine trade war promoted by the EU is a worry in the context of markets that have come a long way in the last 12 months.
Macro Update 29 March 2021
Discover why, in Real Estate, the E in ESG stands for Engagement.
Huge, technological forces are reshaping the world. How can investors remain on the right side?
A case study from our 2030 net zero carbon target for the BMO UK Property Fund.
Macro Update 22 March 2021
Discover the road we’re taking to achieve net zero emissions across all assets under management.
The 2021 Access to Medicine Index reveals how big pharma is tackling health and healthcare access inequalities.